Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01351623 · COMPLETED
Trial details
- NCT number
- NCT01351623
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-09
- Primary completion
- 2016-01-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.